At the San Antonio Breast Cancer Symposium, researchers discussed how results from HER2CLIMB-05 may inform first-line ...

An initial 6-week course of intranasal saline resolved symptoms for 29.5% of 3- to 12-year-olds with obstructive ...

A conservative group has filed a lawsuit against the Los Angeles Unified School District, the nation’s second largest, ...

Cohort 4 data demonstrated positive safety and efficacy results, including additional clinical benefit observed following ...

Moderna & Merck announce 5-year data for intismeran autogene in combo with Keytruda demonstrated sustained improvement in primary endpoint of recurrence-free survival in patients with high-risk stage ...

High probability of technical success in pivotal Phase 3 trial based on unmatched efficacy data for third-line non-small cell ...

Pope Leo XIV has criticized the administration’s treatment of migrants, its antipathy toward Europe and the use of what he characterized as 'diplomacy based on force.' ...

Gedatolisib's NDA for advanced breast cancer treatment has been accepted by the FDA, with a priority review and a PDUFA date set for July 17, 2026. The drug is intended for HR+/HER2–, PIK3CA wild-type ...

This guidance is for integrated care boards (ICBs) and providers of eating disorder services and sets out how to design collaborative, integrated services that support all children, young people, and ...

In a study published in the journal Iraq, Dr. Troels Arbøll analyzed medical prescriptions from ancient Mesopotamia to ...

Lawmakers are eyeing a health care deal this week, but it’s far from the “Great Healthcare Plan” that President Donald Trump ...

Florida doctors, school counselors, or psychologists could face a third-degree felony and $100,000 fine if they advise minors ...